| 标题 |
Abstract C114: Dose escalation results from a first-in-human, phase I/II study of GB263T, a novel EGFR/cMET/cMET trispecific antibody, in patients with advanced EGFR-mutated (EGFRm) non-small cell lung cancer (NSCLC) |
| 网址 | |
| DOI | |
| 其它 |
期刊:Molecular Cancer Therapeutics 作者:Jin-Ji Yang; Nick Pavlakis; Fan Xie; Tong Li; Yi-Long Wu 出版日期:2023-12-01 |
| 求助人 | |
| 下载 | 该求助完结已超 24 小时,文件已从服务器自动删除,无法下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)